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In Brief
The fetal immune system is considered anti-inflammatory; nonetheless, preterm infants are at risk for necrotizing enterocolitis (NEC), a severe intestinal inflammatory disease. Schreurs et al. demonstrate that fetal TNF-a + CD4 + T cells promote gut development early in life. However, in preterm babies these TNFa + CD4
+ T cells can mediate intestinal inflammation, providing a potential mechanism for NEC.
SUMMARY
Although the fetal immune system is considered tolerogenic, preterm infants can suffer from severe intestinal inflammation, including necrotizing enterocolitis (NEC) . Here, we demonstrate that human fetal intestines predominantly contain tumor necrosis factor-a (TNF-a) + CD4 + CD69 + T effector memory (Tem) cells. Single-cell RNA sequencing of fetal intestinal CD4 + T cells showed a T helper 1 phenotype and expression of genes mediating epithelial growth and cell cycling. Organoid co-cultures revealed a dosedependent, TNF-a-mediated effect of fetal intestinal CD4 + T cells on intestinal stem cell (ISC) development, in which low T cell numbers supported epithelial development, whereas high numbers abrogated ISC proliferation. CD4
+ Tem cell frequencies were higher in inflamed intestines from preterm infants with NEC than in healthy infant intestines and showed enhanced TNF signaling. These findings reveal a distinct population of TNF-a-producing CD4 + T cells that promote mucosal development in fetal intestines but can also mediate inflammation upon preterm birth.
INTRODUCTION
Immunity in early life is faced with extraordinary challenges, including upholding of the fetal-maternal equilibrium and avoiding fetus-against-mother responses, unmatched tissue growth, and adaptation to imminent microbial invasion at birth. Studies of cord and infant blood have shown that the infant immune system is characterized by T regulatory (Treg) and T helper 2 (Th2) cells, whereas Th1 cell responses are limited early in life (Micha€ elsson et al., 2006; Prendergast et al., 2012; Zhang et al., 2014) . Further studies of fetal tissues have shown that this bias toward Treg and Th2 cells already exists from the second trimester of gestation in fetal spleens and lymph nodes (Mold et al., 2008) . Several mechanisms have been proposed for the relative tolerance of the fetal immune system (He et al., 2018; McGovern et al., 2017; Mold et al., 2008) . In a recent study, the differential expression of arginase-2 between fetal splenic dendritic cells (DCs) and adult splenic DCs revealed that fetal DCs favor induction of Treg and Th2 cells over Th1 cells (McGovern et al., 2017) . Although the infant immune system clearly differs from the adult immune system, there are suggestions that it is not anti-inflammatory only, because a population of proinflammatory CXCL8-chemokine-producing T cells has been described in infant blood (Gibbons et al., 2014) .
Studies in adults have shown distinct compartmentalization of tissue-resident memory T (Trm) cells (Masopust et al., 2010; Mueller and Mackay, 2016) . We have previously demonstrated that CD4 + CD45R0 + T cells are abundantly present in human intestines, but not in blood, at birth and display tissue-specific expression of chemokine receptors (Bunders et al., 2012) . Furthermore, CD4 + T cell clones in the infant intestine are highly compartmentalized and have limited overlap with clones in the spleen or blood (Bunders et al., 2012) , suggesting that the intestine might harbor a distinctive tissue-resident population of memory CD4 + T cells prior to birth. This observation is supported by subsequent studies describing infant intestines with large numbers of memory CD4 + T cells that express CD69, which allows these cells to remain tissue resident (Thome et al., 2016) .
Because the classical task of T cells in host defense is negligible prior to birth, the physiological role of CD4 + CD45R0 + T cells in the intestine so early during human development remains unclear. There is an increasing appreciation for the effects of cytokines produced by tissue-resident lymphocytes to support tissue regeneration (Karin and Clevers, 2016) . For example, , a cytokine produced by innate intestinal lymphocytes, can contribute to the growth of the intestinal epithelium by inducing proliferation of intestinal stem cells (ISCs) (Lindemans et al., 2015) . However, inadequate control of immune responses can result in severe intestinal inflammation (Maloy and Powrie, 2011; Powrie et al., 1994) . During birth, the fetus leaves the protected maternal environment and is exposed to large numbers of microbes. Strict control of proinflammatory immune responses prevents inflammation of the intestinal mucosa in most cases (Rautava et al., 2012) ; however, preterm birth predisposes infants to necrotizing enterocolitis (NEC), a severe intestinal inflammatory disease that has a 20% mortality rate (Neu and Walker, 2011) and does not occur in term-born infants.
In this study, we investigated the ontogeny of intestinal CD4 + T cells in human fetal intestines and their effects on intestinal development. CD4 + T effector memory (Tem) cells that produced tumor necrosis factor-a (TNF-a) were present very early in fetal intestines from the end of the first trimester, whereas Treg cells were scarce. Figure S1A ). These large numbers of CD4 + T cells prior to birth were unique to the human fetal intestine because intestines of fetal mice at embryonic day 19.5 (E19.5) did not contain T cells ( Figure S1B ). Analyses of human pediatric intestinal samples obtained at surgical reconstruction of congenital abnormalities (median age 4 months) showed that epithelial CD4 + T cells were still abundant at that age (Figures 1A and 1B) . Absolute numbers of CD4 + T cells per cm 2 of tissue were further increased in infant intestinal tissues compared with fetal tissues (Figures 1C and S1C ). These data demonstrate that, unlike in mice, CD4 + T cells were already present early in the human fetal intestinal mucosa and that their numbers further increased with age.
Fetal Intestinal CD4
+ T Cells Are Predominantly Effector
Memory T Cells
In peripheral blood, T cell differentiation follows a linear pathway, starting from mostly naive CD4 + T cells at birth, and requires several years (Durek et al., 2016) . However, in contrast to those in fetal lymph node or cord blood, the majority of fetal intestinal CD4 + T cells were CD45RA Figure 1E ).
Because fetal intestinal CD4 + T cells showed a differentiated memory phenotype, we assessed whether fetal intestinal CD4 + T cells had undergone clonal expansion by using T cell receptor (TCR) RNA sequencing. TCR repertoires from sorted fetal intestinal CD4 + Tem cells contained expanded clones among an overall polyclonal repertoire ( Figure 1G ), demonstrating that fetal intestinal CD4 + T cells had undergone clonal expansion during fetal development and were not derived from public clones. The clonal distribution of intestinal CD4 + T cells in the infant sample was in line with our previously published data (Bunders et al., 2012) . Altogether, these data demonstrate that polyclonal CD4 + T cells with a predominantly effector memory phenotype are present in fetal intestines early in human development.
Fetal Intestinal CD4 + Tem Cells Express CD69 and CD103 but Limited PD1 T cells can be anchored in tissues by specific molecules such as CD103 and CD69 (Mackay et al., 2012; Schoenberger, 2012 Figure 2C ), further indicating compartmentalization of early human T cell responses. Auto-inflammation by T cells in high antigenic environments, such as the intestinal mucosa, is prevented through several mechanisms, including inhibition of T cell effector function by programmed cell death 1 (PD1) (Sharpe et al., 2007 Figure S2A ). In line with the Th1 cytokine profile, T-box transcription factor TBX21 (T-BET) expression was high in fetal intestinal CD4 + T cells ( Figure S2B ).
Treg cells have been described in fetal lymphoid nodes and were next investigated. Frequencies of fetal mesenteric-lymphnode-derived Treg cells were similar to those in two previous studies (Micha€ elsson et al., 2006; Mold et al., 2008) Figures 3D and 3E ). Upon stimulation, 1.6% (IQR 1.5%-3.6%) of infant intestinal CD4 + T cells produced IL-10; however, IL-10 production was almost undetectable in fetal intestinal CD4 + T cells (p < 0.001) ( Figure 3F ). t-SNE analyses showed that fetal . Shown are fetal epithelium (n = 6) and lamina propria (n = 13) samples and infant epithelium (n = 6) and lamina propria (n = 9) samples. (G) TCR clones of fetal and infant epithelium-and lamina-propria-derived CD4 + Tem cells. Shown are fetal epithelium (n = 3) and lamina propria (n = 3) samples and infant epithelium (n = 1) and lamina propria (n = 1) samples. The dotted line represents the cutoff of expanded T cell clones (Bunders et al., 2012; Klarenbeek et al., 2010) Statistical significance was measured by Mann-Whitney U comparisons. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Abbreviations are as follows: lam.
prop., lamina propria; mes. LN, mesenteric lymph node; Tem, effector memory T cells; Tcm, central memory T cells; Tsmc, stem memory T cells; and Tn, naive T cells ( Figure S1 ).
intestinal Treg cells were not tissue resident (CD69 À ), whereas CD69 was expressed by a proportion of infant intestinal Treg cells ( Figure S2E ). Overall, these data demonstrate that Treg cells are less frequent in the fetal intestine than in the infant intestine but increase later during development, as described previously (Thome et al., 2016) . In addition, IL-4 production, which is characteristic of infant-blood-derived CD4 + T cells (Zhang et al., 2014) , did not differ significantly between fetal and infant intestinal CD4 + T cells ( Figure 3F ). Also, CXCL8 production did not differ between intestinal fetal and infant CD4 + T cells ( Figure 4A ). A further separation of epitheliumand lamina-propria-derived CD4 + T cells was observed for fetal cells ( Figure 4A ). Gene-set enrichment analysis showed clustering of related Gene Ontology (GO) terms in unstimulated fetal intestinal CD4 + T cells ( Figure 4B ). One of the largest clusters included GO terms related to T cell activation. Large clusters also included GO terms related to the cell cycle, wingless-related integration site (WNT) signaling, and mitogen-activated protein kinase (MAPK) signaling ( Figure 4B ). Next, we determined the GO terms that significantly differed between stimulated fetal and infant intestinal CD4 + T cells. Stimulated fetal and infant intestinal CD4 + T cells clustered separately; a more homogeneous fetal cell cluster and individual infant clusters indicated higher heterogeneity among infant cell populations ( Figure 4C ). The expression of genes in GO terms summarizing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling, as well as genes in GO terms of IL-12-mediated signaling, was significantly increased in stimulated fetal compared with infant intestinal CD4 + Tem cells ( Figure 4D ).
NF-kB, together with IL-12, mediates the differentiation of Th1 cells (Aronica et al., 1999; Athie-Morales et al., 2004; Hilliard et al., 2002) . Furthermore, genes in the GO term regulation of epithelium morphogenesis were significantly upregulated in stimulated fetal intestinal CD4 + Tem cells, which was in line with the GO terms defining fetal intestinal T cells at baseline (Figure 4D) TNF-a production is strongly dependent on post-transcriptional regulation by several other proteins, in particular MAP-kinaseactivated protein kinase 2 (MAPKAP2) (Brook et al., 2000; Kotlyarov et al., 1999) , and MAPKAP2 mRNA was significantly upregulated in fetal intestinal CD4 + Tem cells compared with infant cells (Figures 4E and S4B) , most likely allowing for the increased protein detected in fetal intestinal CD4 + T cells. GO terms representing the MAPK cascade were also already dominantly present in the unstimulated fetal intestinal CD4 + T cells ( Figure 4B ). Next to the Th1 cell phenotype, fetal CD4 + T cells were further characterized by GO terms summarizing genes involved in the cell cycle and tissue development. In line with this, genes encoding proteins involved in regulating the cell cycle (such as PTMA and SET; Eilers et al., 1991; Fan et al., 2003) and encoding proteins involved in transcription factor networks mediating tissue and T cell development (such as HSPA8 and NACA; Lehtinen et al., 2006; Mendillo et al., 2012) were expressed significantly more in stimulated fetal than in infant intestinal CD4 + Tem cells. Lastly, genes regulating cell metabolism and promoting cell growth (ENO1, ODC1, NAMPT, PFKP, and STK4 [Auvinen et al., 1992; Gerner et al., 2018; Meienhofer et al., 1979; Stefanini, 1972; Abdollahpour et al., 2012] ) were significantly upregulated in fetal compared with infant stimulated intestinal CD4 + T cells. Altogether, these scRNA-seq data demonstrate that fetal intestinal CD4 + T cells exhibit enhanced production of Th1-cell-related cytokines, supporting our data obtained by multi-parameter flow cytometry. Furthermore, genes involved in the cell cycle and tissue growth were significantly upregulated in fetal intestinal CD4 + T cells, indicating a unique T cell phenotype in fetal intestines and pointing toward a potential role in tissue development.
TNF-a Has a Dose-Dependent Effect on Fetal ISC Development
The lamina propria envelopes ISCs in the crypts, allowing close contact between lamina-propria-derived CD4 + T cells and ISCs, whereas epithelial CD4 + T cells are positioned between the intestinal epithelial cells (Bunders et al., 2012) . The effect of TNF-a, the predominant cytokine produced by fetal intestinal CD4 + T cells, on intestinal development was assessed in ISC organoid cultures. ISCs from fetal intestinal tissues were isolated and seeded to grow into organoids (Sato and Clevers, 2013) . Cells from organoids strongly expressed leucine-rich-repeatcontaining G-protein-coupled receptor (LGR5) mRNA, verifying the presence of ISCs in fetal intestinal epithelium-derived organoids ( Figure S5A ). Furthermore, we confirmed expression of mRNA of TNF-a receptors (TNFRSF1A and TNFRSF1B) by fetal ISCs ( Figure S5B ). Next, the effect of TNF-a on fetal ISCs in in vitro organoid systems was determined. In cultures with 0.2 ng/mL TNF-a, the numbers of organoids were significantly higher than in control cultures without TNF-a ( Figures 5A and 5B). In contrast, TNF-a concentrations R 20 ng/mL reduced the number of developing organoids and impaired ISC proliferation ( Figures 5A and 5B), in line with the described role of high concentrations of TNF-a in inducing apoptosis (Begue et al., 2006; Sands and Kaplan, 2007) . WNT signaling is critical for the proliferation of stem cells (Kretzschmar and Clevers, 2017) , and NF-kB can further enhance WNT signaling and upregulate expression of WNT target genes (Schwitalla et al., 2013) , promoting ISC proliferation. Whole-genome RNA sequencing of fetal ISCs stimulated with different concentrations of TNF-a showed that the expression of previously identified targets of WNT signaling, such as ASCL2 and FSTL1 (van der Flier et al., 2009; Schwitalla et al., 2013) , was high in ISC cultures at low concentrations of TNF-a and decreased with increasing TNF-a concentration ( Figure S5C ). Organoid cultures with high TNF-a concentrations furthermore exhibited increased expression of genes mediating apoptosis, such as FOXO1 and TNFSF10 ( Figure S5D ). Together, these data show that TNF-a has a dose-dependent effect on fetal ISC development whereby low concentrations support ISC growth and high concentrations of TNF-a prevent ISC proliferation. 5D ). TNF-a blockade abolished fetal-T-cell-mediated enhanced organoid outgrowth, demonstrating that this process was TNF-a dependent ( Figures  5C and 5D ). In contrast, high fetal T cell numbers impeded ISC proliferation, indicating an inhibitory effect of fetal intestinal CD4 + T cells ( Figures 5E and 5F ). This inhibitory effect of high numbers of fetal intestinal CD4 + T cells was again TNF-a dependent given that TNF-a blockade restored ISC outgrowth and organoid numbers. Collectively, these in vitro data from intestinal CD4 + T cell and ISC co-culture systems show that intestinal fetal CD4 + Tem cells have a dose-dependent and TNF-a-mediated effect on ISC proliferation; this effect supports intestinal epithelial growth and development under physiological conditions but can prevent epithelial growth at high concentrations.
Inflamed Intestines of Preterm Infants Show an Enhanced TNF-a Signature
Preterm infants are at risk of developing intestinal inflammation that can lead to NEC (Neu and Walker, 2011) . Our studies show that early in human development TNF-a-producing CD4 + T cells are preferentially present in fetal intestines and can support intestinal development but that high concentrations of TNF-a can also inhibit epithelial growth in vitro. We hypothesized that preterm birth and antigen exposure can result in further activation and recruitment of TNF-a-producing CD4 + Tem cells in NEC, whereas preterm infants without NEC would have a phenotype resembling CD4 + T cells in older children. In comparison with fetal tissues, tissues from infants with NEC showed large numbers of T cells in the epithelium and lamina propria of NEC-affected tissues ( Figure 6A ). We further isolated cells from the intestinal tissues of six preterm infants with NEC (median 25 weeks of gestation at birth; median age 9.5 days at surgery) and observed that 57% (median, IQR 49%-60%) of CD3 + T cells were CD4 + 8 À T cells. The frequencies of naive CD4 + T cells were significantly lower in the inflamed intestines of preterm infants with NEC and showed a more differentiated phenotype than intestinal CD4 + T cells derived from preterm infants without intestinal inflammation or infants born at term ( Figures  6B and 6C ). Intestinal CD4 + T cells derived from NEC tissues produced TNF-a already at baseline, and this was further upregulated upon stimulation with PMA-ionomycin ( Figures S6A  and 6D ), whereas IL-10 production by CD4 + T cells from NEC tissues was absent ( Figures 6D and 6E) . Overall, these data show that CD4 + T cells in inflamed intestinal tissue of preterm infants with NEC had an effector memory phenotype with preferential TNF-a production. To determine whether TNF-a and genes downstream of TNF signaling were expressed in NEC tissues, we quantified mRNA expression in NEC tissues. The mRNA of prop., lamina propria; P/I, PMA-ionomycin; GO, Gene Ontology; AUC, area under the curve; sign., signaling; and reg., regulation. Sample sizes are as follows: fetal epithelium, n = 2; fetal lam. prop., n = 2; infant epithelium, n = 4; and infant lam. prop., n = 4. See Figure S4 .
the genes TNFA, NFKBIA, TNFAIP2, and TNFAIP3 was significantly enhanced in tissues derived from NEC patients compared with infants born at term, consistent with higher TNF-a signaling ( Figure 6F ). Ex vivo analyses of fetal intestinal tissues without inflammation showed a trend toward higher NFKBIA and TNFAIP3 expression than in intestines from infants born at term ( Figure 6F ), consistent with the observed TNF-a production ex vivo. Together, these data show that CD4 + Tem cells were increased in NEC tissues and preferentially produced TNF-a. Furthermore, a gene expression signature consistent with enhanced TNF-a signaling was observed in intestinal tissues from preterm infants with NEC. (2017) provided a mechanism for this tolerogenic immune status by demonstrating that enhanced arginase-2 activity in fetal DCs derived from spleens promoted the induction of Treg cells and diminished TNF-a production by T cells. The authors also showed that fetal intestines harbored predominantly classical DC1s (cDC1s), which can induce Th1 responses, rather than tolerance-inducing splenic classical cDC2s. IL-12 production by DCs is critical for the polarization toward Th1 cells (Athie-Morales et al., 2004) , and fetal intestinal CD4 + T cells indeed showed upregulation of genes mediated by IL-12 signaling. The presence of cDC1s appears to be unique to fetal intestines given that cDC2s are prevalent in infant and adult intestines (Granot et al., 2017) . The data presented here demonstrate a predominance of TNF-a-producing CD4 + T cells in intestines of fetuses with a Th1 cell transcriptomics profile, whereas a broadened intestinal CD4 + T cell repertoire, including functional Treg cells, was observed in infants. Intestines of preterm infants born at the beginning of the third trimester without intestinal inflammation harbored an increased number of naive CD4 + T cells, suggesting that substantial modifications occur at this time. Tissue-specific compartmentalization of human CD4 + T cells allows fetal CD4 + T cells to have functional differences that can be tailored toward the specific requirements of the respective tissues at that particular developmental stage, such as TNF-a-producing CD4 + T cells in the intestine of fetuses and predominantly Treg and Th2 cell responses in the blood to enable maternal-fetal equilibrium during pregnancy. The memory features of fetal intestinal CD4 + Tem cells, including IRF4 expression and clonal expansion, suggest a TCR-triggered memory induction rather than a memory-like induction in a lymphopenic environment (Le Saout et al., 2008) . However, the origins of the antigens responsible remain elusive and might include maternal antigens (Mold et al., 2008) , autoantigens, or even antigens derived from microbes passing through the placenta (Collado et al., 2016) . Further studies are needed to answer these fundamental questions. During the second trimester of gestation, corresponding to the time at which fetal tissues were investigated in this study, fetal intestinal growth accelerates to peak velocity (Weaver et al., 1991) . Inflammation is generally perceived to be disadvantageous during fetal development, and in utero infections that trigger immune responses are associated with impaired fetal growth (Mor et al., 2017) . However, immune cells have been recently recognized for their role in tissue regeneration of the intestinal epithelium after tissue damage (Lindemans et al., 2015) . Here, we demonstrated that fetal intestinal CD4 + T cells by means of TNF-a at relatively low concentrations promoted the outgrowth of fetal ISCs, revealing a supportive role of TNF-a produced by T cells in mucosal development prior to birth. TNF-a has been shown to facilitate tumor growth (Orosz et al., 1993) through NF-kB enhancement of WNT signaling (Schwitalla et al., 2013) . Human fetal cells from other tissues, such as microglial cells, also exhibit TNF-a-biased cytokine production (Chao et al., 1995; Zolti et al., 1991) , suggesting a shared pathway in development. In contrast to humans, fetal mice did not have T cells in the intestinal mucosa, and murine fetal intestinal stem cells can produce endogenous growth factors, rendering them less dependent on exogenously produced factors (Nusse et al., 2018) . Furthermore, TNF-deficient mice have normal epithelial development under homeostatic conditions (Kuprash et al., 2005 Figure S6 .
the intestinal CD4 + T cell compartment in preterm infants with NEC resembled fetal intestines, intestines of preterm infants without NEC largely harbored naive CD4 + T cells, reflective of observations in older infants. Furthermore, intestinal tissues of infants with NEC showed high expression of genes upregulated in response to TNF-a signaling, revealing a TNF-a footprint in NEC tissues. Thus, peak incidence of NEC occurs at a time during human immune development when dramatic changes in immune cell populations take place. The high susceptibility of prematurely born infants to NEC might be furthermore enhanced by limited immune regulatory properties. PD1 was low in fetal compared with infant intestinal CD4 + T cells, and IL-10 + Treg cells were scarce in fetal intestines, as well as in NEC samples, the latter of which is in line with previous data (Weitkamp et al., 2013) . Because of the lack of appropriate animal models and the unfeasibility of longitudinal samples obtained before and during NEC in infants, it is difficult to unequivocally determine causes and effects of TNF-a + CD4 + T cells in NEC. However, the data presented in this study suggest a model in which, depending on the individual maturation status of the intestinal T cell compartment in the infant at the time of preterm birth, premature exposure to the external environment can result in intestinal inflammation and NEC. Further studies are needed to determine whether anti-TNF treatments that are successfully used in inflammatory bowel diseases in adults (Sands and Kaplan, 2007) also represent a therapeutic option in NEC.
In conclusion, our findings provide a new framework for intestinal immune ontogeny in which intestinal CD4 + Tem cells can support mucosal development prior to birth in the in utero environment and reconcile our fundamental understanding of earlylife human T cell responses with the increased risk of intestinal inflammation in preterm infants.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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DECLARATION OF INTERESTS STAR+METHODS
Center of Amsterdam (AUMC) and the University Medical Center Hamburg-Eppendorf. Tissues from 3 prematurely born infants without NEC (gestational ages of two infants born at 25 weeks gestation and one infant born at 26 weeks gestation) were collected at surgery at the Pediatric Surgery Center of Amsterdam (AUMC) and the University Medical Center Hamburg-Eppendorf. Blood and cord blood samples were obtained anonymously from healthy volunteers at the AUMC, Amsterdam. Donor specifics are provided in Table S1 . The guardians of pediatric donors provided informed consent for the use of materials in this study. Tissues were obtained in Amsterdam with approval of the ethical committee of the AUMC (University of Amsterdam) and in Hamburg with approval of the ethics committee of the medical association of the Freie Hansestadt Hamburg (Ä rztekammer Hamburg) and in accordance with the Declaration of Helsinki. The intestinal tissue of an adult pregnant C57BL/6J mouse and 3 pups of her litter were obtained in accordance with the Institutional Review Board ''Behö rde f€ ur Soziales, Familie, Gesundheit und Verbraucherschutz'' (Hamburg, Germany).
METHOD DETAILS
Lymphocyte isolation from human blood and tissue specimens Blood and tissue samples were processed in the laboratory within 12 hours of procurement. Blood samples were collected in heparine-coated tubes. The mononuclear cell fraction was isolated using a density gradient. Blood was diluted 1:1 with Hank's Balanced Salt Solution (HBSS; Lonza), then layered on top of Lymphoprep (Axis-Shield) and centrifuged for 22 minutes at room temperature at 1000G with 120 seconds acceleration and no break. The mononuclear cell fraction was aspirated and washed with phosphate buffered saline (PBS). Mesenteric lymph nodes were cleaned with PBS after which the tissue was minced with scissors and digested for 2x 30 minutes at 37 C with Iscove's Modified Dulbecco's Medium (IMDM; Lonza) supplemented with 1 mg/ml (0.15 U/mg) Collagenase D (Roche), 1% fetal bovine serum (FBS; Biological Industries), and 1000 U/ml DNAse type I (Worthington Biochemical Corporation). The supernatant containing the cells was filtered through a 70 mm strainer (Falcon, Corning) to obtain a single cell solution. Lymphocytes were then isolated by density gradient centrifugation using Lymphoprep as described for blood samples. Intestinal lymphocytes were isolated as described before (Schreurs et al., 2017) . Fetal intestines were cut open longitudinally and cleaned from meconium by washing in PBS until PBS was clear. Intestinal tissues from older donors were washed with PBS until PBS was clear after which the muscle layer was removed with scissors and again washed if needed. Sizes of the intestinal tissues without the muscle layer were documented. Intestinal tissues were next cut into 0.5x0.5 cm segments and incubated for 2x 20 minutes, in a shaking water bath (100 strokes/minute), at 37 C with IMDM supplemented with 5 mM ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich), 2 mM 1,4-dithiothreitol (DTT; Sigma-Aldrich) and 1% FBS to detach the epithelial layer. The supernatant was filtered through a 70 mm cell strainer to obtain a single cell solution. Epithelial lymphocytes were isolated by density gradient centrifugation using Lymphoprep as described for blood lymphocytes. The intestinal tissue, now devoid of the epithelial layer, was minced and digested for 2x 30 minutes at 37 C with IMDM (Lonza) supplemented with 1 mg/ml (0.15 U/mg) Collagenase D (Roche), 1% fetal bovine serum (FBS; Biological Industries), and 1000 U/ml DNAse type I (Worthington Biochemical Corporation). The supernatant containing the cells was filtered through a 70 mm strainer (Falcon, Corning) to obtain a single cell solution. Lamina propria lymphocytes were isolated from the single cell suspension using a Percoll gradient (Sigma-Aldrich); standard isotonic Percoll solution (SIP) was prepared by supplementing 100% Percoll with 10% 10X PBS, using an additional 1X PBS resulted in 60% SIP solution. After isolation, the number of viable cells was counted using Trypan blue (Sigma-Aldrich).
Lymphocyte isolation from murine tissue specimens One adult (10-14 week old) pregnant C57BL/6J mouse and her pups were sacrificed in the late stage of pregnancy (day 19.5), and the fetuses were excised. The intestines were harvested. Peyer's patches from maternal intestines were excised. Maternal and fetal small and large intestine was separated, cut longitudinally and washed with PBS until clear. For isolation of intraepithelial lymphocytes, the intestinal tissue was incubated in HBSS (Gibco) supplemented with 17% 10X HEPES (Sigma-Aldrich), 17% FBS (Gibco), and 1 mM DTT (Sigma-Aldrich) for 20 minutes at 37 C, shaking (200 strokes/min). The remaining tissue was then minced and incubated from 40 minutes at 37 C, shaking (200 strokes/min) in Roswell Park Memorial Institute (RPMI; Sigma-Aldrich) 1640 medium, supplemented with 1 mM CaCl 2 (Sigma-Aldrich), 1 mM MgCl 2 (Sigma-Aldrich), 1% FBS, 1 mg/ml Collagenase NB 6 (Serva), and 10 U/ml DNAse I (Roche) to collect lamina propria lymphocytes. Epithelial and lamina propria-derived lymphocytes were further enriched by Percoll gradient centrifugation (GE Healthcare).
Stimulation assays for cytokine production by lymphocytes Cells were resuspended in IMDM supplemented with 10% FBS (Biological Industries), 50 mg/ml Gentamicin (Gibco) and 60 mM 2-mercaptoethanol (Sigma-Aldrich) and either left unstimulated, stimulated with 1.5 mg/ml anti-CD3 (1XE; Sanquin) and 2 mg/ml anti-CD28 (15E8; Sanquin), or stimulated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) and 1 mg/ml ionomycin (Sigma-Aldrich), a relatively low concentration, for 12 hours. 7 mg/ml brefeldin A (Sigma-Aldrich) was added after one hour incubation. Cells were kept at 37 C and 5% CO 2 for the duration of the stimulation. Figure S1C and Figure S6B ). Studies were performed using lamina propria-derived CD4 + T cells due to the limited cell numbers isolated from intestinal epithelium. Resources table for all antibodies) , surface-stained cells were washed, fixated with 1X Fixation/Permeabilization reagent (eBioscience) for 15 minutes on a shaker (600 strokes/minute) and incubated with antibodies in 1X Permeabilization Buffer (eBioscience) for 30 minutes at 4 C on a shaker (600 strokes/minute). Ultracomp eBeads (eBioscience) were used to determine spectral overlap. Stained cells were acquired on a LSR Fortessa Flow Cytometer (BD Biosciences) using FACSDIVA software (version 8; BD Biosciences) within 24 hours after staining and analyzed using FlowJo software (version 10.5.0; Treestar). Murine stained cells were acquired on a LSRII Flow Cytometer (BD). For t-distributed stochastic neighbor embedding (t-SNE) analyses within FlowJo software (Version 10.5.0), the CD4 + T cell population was first downsampled to 10,000 events. Relevant compensated parameters were selected and subsequently two new parameters (t-SNE1 and t-SNE2) were created, allowing for the visualization of the size and overlap of multiple fluorescent labels of interest in one t-SNE plot.
TCR RNA Sequencing
Fetal and infant epithelial and lamina proria-derived sorted CD4 + Tem cells were collected and lysed in 350 mL Buffer RLT (Qiagen) plus 1% 2-mercaptoethanol (Sigma-Aldrich) and stored at À80 C until RNA isolation, performed with RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. cDNA was synthesized with custom primers containing: a specific sequence for TCRb C region (Klarenbeek et al., 2010) , a Unique Molecular Identifier (UMIs) (Kivioja et al., 2011) and MiSeq (Illumina) sequencing adaptors. cDNA synthesis was performed using SuperScriptÔ III Reverse Transcriptase (Thermo Fisher Scientific) according to manufacturer's instructions for custom primers. cDNA was purified using Agencourt AMPure XP beads (Beckman Coulter) using 1:1 ratio. Purified cDNA (125 ng) was used for PCR using TCRb V genes forward primers (adapted from van Dongen et al., 2003) and MiSeq adaptor sequences as reverse primers. PCR was performed using HOT FIREPolÒ DNA Polymerase (Solis BioDyne) as follows: 96 C 15 minutes, 403 (96 C for 30 seconds, 60 C for 60 seconds, 72 C for 30 seconds), 72 C for 10 minutes. The PCR products were purified (Agencourt AMPure XP beads) and further processed for Next-Generation Sequencing (NGS). Purified PCR products were processed for NGS using MiSeq Reagent Kit v3 600 cycles (Illumina) according to the manufacturer's instructions. Sequencing was performed on the Illumina MiSeq platform. 3102 clones per sample were randomly selected and used for analysis. TCRb clones were identified according to their unique V-CDR3-J combination via a customized bioinformatics pipeline as described earlier (Klarenbeek et al., 2010) .
CD4
+ T cell sorting and subsequent single-cell RNA-sequencing PMA-ionomycin and subsequently sorted into a 384-well plate. Cells were directly dissolved in primer mix. Single cell library preparation and sequencing single cell RNA-seq Libraries were prepared using the CEL-Seq2 protocol as previously described (Hashimshony et al., 2016) . cDNA libraries were sequenced on an Illumina NextSeq500 using 75bp paired-end sequencing (Utrecht Sequencing Facility).
Single CD4 + T cell RNA-sequencing data analysis Reads obtained from sequencing fetal and infant T cells were mapped and deconvoluted into single cell transcriptomes using the zUMIs pipeline (version 2.0.5) (Parekh et al., 2018) . This included mapping with STAR 2.6.0c and counting with Rsubread 1.30.5. GRCh38 was used as a reference genome. All further analysis steps were performed in R 3.5.1 using the Seurat framework (version 2.3.4) (Butler et al., 2018) . First, all cells were combined into one Seurat single cell object. Cells with less than 100 detected genes were removed as well as genes expressed in less than 50 cells and cells with more than 25% of reads from mitochondrially encoded genes. Expression data was normalized and scaled with regression on number of detected genes (nGene) and number of detected unique molecular identifiers (nUMI). Outliers in a nGene/nUMI plot were removed from the dataset. One small cluster of cells was positive for myeloid cell markers and was removed from the dataset. In total 2147 fetal intestinal T cells and 754 infant intestinal T cells were part of the final dataset, with an overall smaller gene detection rate for the infant cells. For data visualization, t-SNE plots of all unstimulated or all stimulated (PMA and ionomycin) cells were generated based on a principal component analysis (PCA) of the most variable genes in the dataset. Gene ontology (GO) term enrichment analysis was performed on a pseudo bulk of all CD4 + Tem cells in each group to take into account potential quality differences. Specifically, genes were sorted by their summarized expression values and subjected to the gseGO() function of the clusterProfiler package (Yu et al., 2012) using standard settings and an adjusted p-value cutoff of 0.05 to determine GO biological process terms characterizing the transcriptomic signatures of both groups. A network of GO terms uniquely found in fetal intestinal CD4 + Tem cells was calculated using the emapplot() function to visualize genes shared between terms. The resulting plot was modified for clarity by curating groups of similar GO terms and assigning representative labels. Analysis of the enrichment of representative GO terms on a single cell level was performed using the AUCell algorithm (Aibar et al., 2017) and resulting area under the curve (AUC) values were plotted for each cell individually. To identify a stimulation specific signature for fetal intestinal CD4 + Tem cells, differentially expressed genes were determined for pseudo-bulks of all stimulated versus all unstimulated fetal CD4 + Tem cells using DESeq2 (Love et al., 2014) with inclusion of donor identity in the modelling and an adjusted p-value cutoff of 0.05. To identify differences compared to infant intestinal CD4 + Tem cells the results were filtered for genes with detection in at least 20 stimulated infant CD4 + Tem cells and the Seurat inherent function FindMarkers() was used to determine which candidate genes were differentially expressed between fetal and infant intestinal CD4 + Tem cells (adjusted p-value cutoff 0.05). Selected genes were visualized in a heatmap.
Intestinal organoid culture
The epithelial layer from fetal intestines, containing the intestinal stem cells (ISCs), was detached using EDTA and DTT as described in the segment 'Lymphocyte isolation from human blood and tissue specimens', with the modification that tissues were incubated at 4 C for 1 hour on a shaker (600 strokes/minute). Single cells were suspended in 10 ml Matrigel (Corning) drops. The Matrigel was allowed to solidify for 10 minutes at 37 C after which 0.5 ml human intestinal stem cell medium (HISC) was added to each well. HISC comprises Advanced Dulbecco Modified Eagle Medium (DMEM)/F12 supplemented with 1% 1X GlutaMAX, 1% 1X Penicillin/Streptomycin, 1:25 1X B27 supplement, 1:50 1X N2 supplement, 1:500 1X mouse epidermal growth factor (EGF; all Invitrogen), 1% 1M HEPES, 500 mM n-Acetyl-L-cysteine, 10 mM [Leu 15 ]-Gastrin, 1M Nicotinamid, 20 mM SB202190 (all Sigma-Aldrich), Noggin 20%, Rspondin 10%, WNT3a (all three AUMC conditioned home-made medium), 500 mM A83-01 (Tocris), and 10 mM ROCK inhibitor (Stemcell Technologies). Medium was refreshed every 2-3 days. Once the organoids developed (5-10 days after initial seeding), they were passaged once per week to remove dead cells, debris, and to break up larger organoids. To passage organoids, the organoids were taken up in ice-cold advanced DMEM/F12 supplemented with 1% 1X GlutaMAX, 1% 1X Penicillin/Streptomycin, and 1% 1M HEPES. The organoids were broken up with two repeating pipetting cycles (20x vigorous pipetting) using tips of 200 ml and 20 ml volume. If needed single cell suspension was obtained upon treatment of the organoids with TrypLE express (Invitrogen) for 5-7 minutes at 37 C. Upon a minimum of three passages organoids were used for experiments. Organoid development was monitored for 12 days in HISC medium supplemented with 0, 0.2, 2, 20, 200 ng/ml recombinant human (rh) TNF-a (Bio-Techne). Medium (including rh-TNF-a) was refreshed every 2-3 days. Organoid development was measured by taking 5X and 20X images with a Leica (DM IRB) inverted microscope on day 12. The images were used to count the number of organoids using ImageJ (version 1.50i) software. Organoids were collected for subsequent RNA-seq.
Furthermore, we developed CD4 + T cell-ISC co-culture systems. 
Immunohistochemistry (IHC)
Sections of formalin-fixed paraffin-embedded human intestinal tissue samples were dewaxed and rehydrated, after which they were stained in an automatic immunostainer (Benchmark Ultra; Ventana Medical Systems). Tissue specimens were stained for structural components with hematoxylin & eosin (Klinipath & Merck) and T cells cells were visualized with an antibody against CD3 (Thermo Fisher Scientific), using a 3,3 0 -diaminobenzidine detection kit (OptiViewDAB; Ventana medical Systems) and counterstaining cell nuclei with hematoxylin II and bluing agent (both Ventana Medical Systems). Stained tissue samples were evaluated and images were acquired (10X) using a Leica (DM IRB) inverted microscope.
Statistical analysis
Statistical significance of differences was assessed using nonparametric Mann-Whitney U tests, or ANOVAs with Bonferroni's corrections where appropriate. The software package Graphpad Prism (version 7; GraphPad Software) was used to analyze data and to perform statistical analyses. Median frequencies and interquartile ranges (IQRs) are given in figures and text unless otherwise stated. Values of p<0.05 were considered significant. Details on statistical tests used, the value of N and what the data represent can be found in the respective figure legends.
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